Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRL | P40313 | 2/20 | 0.80 |
| ▸ | TMPRSS11D | O60235 | 1/20 | 0.80 |
| ▸ | PSMB5 | P28074 | 16/20 | 0.79 |
| ▸ | PSMB9 | P28065 | 3/20 | 0.79 |
| ▸ | PSMB8 | P28062 | 3/20 | 0.79 |
| ▸ | PSMB10 | P40306 | 3/20 | 0.79 |
| ▸ | PSMB2 | P49721 | 3/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.79 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.79 |
| ▸ | CYP3A7 | P24462 | 2/20 | 0.79 |
| ▸ | CYP3A43 | Q9HB55 | 2/20 | 0.79 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.79 |
| ▸ | PSMD11 | O00231 | 1/20 | 0.79 |
| ▸ | PSMD12 | O00232 | 1/20 | 0.79 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.79 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.79 |
| ▸ | PSMD3 | O43242 | 1/20 | 0.79 |
| ▸ | CTSB | P07858 | 1/20 | 0.79 |
| ▸ | PSMC3 | P17980 | 1/20 | 0.79 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20825238 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL15413127 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL20218351 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL84543 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL18257553 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL23616318 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL8080983 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL8075093 | 1.00 | CTRL (0.80) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL20825237 | 0.95 | TMPRSS11D (0.75) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 | |
| SCHEMBL19851642 | 0.95 | TMPRSS11D (0.75) | CTRLTMPRSS11DPSMB5PSMB9PSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800809-B2 | Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof | LAURUS LABS LIMITED (IN) | 2020-10-13 | — | — | US | disclosed |
| US-20190284231-A1 | PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LAURUS LABS LIMITED (IN) | 2019-09-19 | — | — | US | disclosed |
| WO-2016185450-A1 | AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LAURUS LABS PRIVATE LIMITED (IN) | 2016-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10800809-B2 | Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof | SF3B5, PRCP, GBA1 | CTRL 10/4885TMPRSS11D 513/4885PSMB5 36/4885 |
| US-20190284231-A1 | PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | SF3B5, PRCP, GBA1 | CTRL 10/4885TMPRSS11D 513/4885PSMB5 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.